Effect of the Presence of t(11;14) for Patients With AL Amyloidosis Treated With Bortezomib-Containing Regimens: Experience From the Amyloidosis Program of Calgary

Clin Lymphoma Myeloma Leuk. 2023 Jul 17:S2152-2650(23)00213-6. doi: 10.1016/j.clml.2023.07.004. Online ahead of print.NO ABSTRACTPMID:37532664 | DOI:10.1016/j.clml.2023.07.004
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Source Type: research